CI
NRXPW

Cowen Inc’s NRX Pharmaceuticals Warrant NRXPW Stock Holding History

Cowen Inc’s Portfolio NRXPW Stock Details NRXPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$15K Buy
+67,000
New +$11.9K ﹤0.01% 393
2018
Q4 		– Sell
-20,043
Closed -$9K – 430
2018
Q3 		$9K Buy
20,043
+3,567
+22% +$1.63K ﹤0.01% 463
2018
Q2 		$6 Buy
+16,476
New +$7.54K ﹤0.01% 486

Other funds holding NRXPW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
VAS
VR Advisory Services Camana Bay, Grand Cayman, Cayman Islands $845M AUM 22.79% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Cowen Inc's NRXPW Position: Q2 2019 in Review

Cowen Inc opened a new position in NRX Pharmaceuticals Warrant (NRXPW) in Q2 2019: 67,000 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #393 among its holdings. This is a return to the name: Cowen Inc previously reported a position in NRXPW as recently as Q3 2018.

Cowen Inc first reported a position in NRXPW in Q2 2018 and has held it in 3 quarters since. 19 funds tracked by Wall St. Rank hold NRXPW as of Q2 2019.

  • Cowen Inc held 67,000 shares of NRX Pharmaceuticals Warrant worth $15K as of Q2 2019.
  • NRX Pharmaceuticals Warrant was a new Cowen Inc position in Q2 2019.
  • NRX Pharmaceuticals Warrant made up ﹤0.01% of Cowen Inc's portfolio in Q2 2019, its #393 holding.
  • Cowen Inc first reported a position in NRX Pharmaceuticals Warrant in Q2 2018 and has held it in 3 quarters since.
  • 19 funds tracked by Wall St. Rank held NRX Pharmaceuticals Warrant as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.